Pharmacologic treatments for covid-19 patients

Bromhexine vs Standard care

This comparison will not be updated. Last search date 21 Jan, 2022.


Hospitalized patients

Forest plots
(last update: 2021-04-13)

Summary of findings
(last update: 2022-03-31)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=84

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
IRCT20151227025726N24
Tolouian R, J Investig Med, 2021
Full text
Commentary
Commentary
No specific funding

Bromhexine

Standard care

RCT Patients with confirmed COVID-19 pneumonia (symptomatic, unclear severity) admitted to a single center in Iran N=111
High
Details

Full description

IRCT20200317046797N4
Ansarin K, BioImpacts, 2020
Full text
Commentary
Public/non profit

Bromhexine

Standard care

RCT Patients with COVID-19 (unclear severity) at a single center in Iran N=78
Some concerns
Details

Full description

NCT04273763
Li T, Clin Transl Sci , 2020
Full text
Commentary
Public/non profit

Bromhexine

Standard care

RCT Patients with confirmed or suspected COVID-19 (mild-moderate) admitted to a single center in China N=18
Some concerns
Details

Full description